title: [Use of a mini-sequencing test, followed by the MALDI-TOF mass-spectrometric analysis to evaluate rifampicin and izoniazid resistance in Mycobacterium tuberculosis circulating in the Russian Federation].
authors.forename: M V
authors.initials: MV
authors.lastname: Afanas'ev
authors.forename: L N
authors.initials: LN
authors.lastname: Ikriannikova
authors.forename: E N
authors.initials: EN
authors.lastname: Il'ina
authors.forename: T G
authors.initials: TG
authors.lastname: Smirnova
authors.forename: E E
authors.initials: EE
authors.lastname: Larionova
authors.forename: A V
authors.initials: AV
authors.lastname: Kuz'min
authors.forename: L N
authors.initials: LN
authors.lastname: Chernousova
authors.forename: E Iu
authors.initials: EIu
authors.lastname: Kamaev
authors.forename: S N
authors.initials: SN
authors.lastname: Skorniakov
authors.forename: V N
authors.initials: VN
authors.lastname: Kinsht
authors.forename: A G
authors.initials: AG
authors.lastname: Cherednichenko
authors.forename: V M
authors.initials: VM
authors.lastname: Govorun
mesh_terms: D000995:Antitubercular Agents / Q000494:pharmacology; D004269:DNA, Bacterial / Q000032:analysis*; D024901:Drug Resistance, Multiple, Bacterial / Q000235:genetics*; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology*; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000235:genetics* / Q000302:isolation & purification; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods*; D010641:Phenotype; D015203:Reproducibility of Results; D012293:Rifampin / Q000494:pharmacology*; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / Q000379:methods*; D014376:Tuberculosis / Q000188:drug therapy / Q000382:microbiology
chemical_list: D000995:Antitubercular Agents; D004269:DNA, Bacterial; D007538:Isoniazid; D012293:Rifampin